Fundamental Analysis of VAPOTHERM INC(NYSE:VAPO) stock

Fundamental Rating

VAPO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. VAPO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, VAPO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VAPO has reported negative net income.

VAPO had a negative operating cash flow in the past year.

VAPO had negative earnings in each of the past 5 years.

In the past 5 years VAPO always reported negative operating cash flow.

1.2 Ratios

VAPO has a Return On Assets of -86.17%. This is in the lower half of the industry: VAPO underperforms 79.70% of its industry peers.

		Industry Rank	Sector Rank
ROA	-86.17%
ROE	N/A
ROIC	N/A

ROA(3y)-59.67%

ROA(5y)-53.68%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

VAPO has a worse Gross Margin (36.12%) than 66.83% of its industry peers.

In the last couple of years the Gross Margin of VAPO has declined.

VAPO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.12%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-14.95%

GM growth 5Y-5.98%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VAPO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for VAPO has been increased compared to 1 year ago.

The number of shares outstanding for VAPO has been increased compared to 5 years ago.

The debt/assets ratio for VAPO is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -9.96, we must say that VAPO is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of VAPO (-9.96) is worse than 76.73% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-9.96

ROIC/WACCN/A

WACC10.3%

2.3 Liquidity

VAPO has a Current Ratio of 3.04. This indicates that VAPO is financially healthy and has no problem in meeting its short term obligations.

VAPO has a Current ratio (3.04) which is comparable to the rest of the industry.

A Quick Ratio of 1.61 indicates that VAPO should not have too much problems paying its short term obligations.

VAPO has a worse Quick ratio (1.61) than 66.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.04
Quick Ratio	1.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VAPO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.56%, which is quite impressive.

Looking at the last year, VAPO shows a decrease in Revenue. The Revenue has decreased by -3.95% in the last year.

VAPO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.

EPS 1Y (TTM)34.56%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q69.64%

Revenue 1Y (TTM)-3.95%

Revenue growth 3Y11.57%

Revenue growth 5Y13.41%

Revenue growth Q2Q11.96%

3.2 Future

VAPO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.76% yearly.

Based on estimates for the next years, VAPO will show a quite strong growth in Revenue. The Revenue will grow by 18.62% on average per year.

EPS Next Y81.61%

EPS Next 2Y35.65%

EPS Next 3Y23.77%

EPS Next 5Y18.76%

Revenue Next Year5.53%

Revenue Next 2Y10.65%

Revenue Next 3Y11.78%

Revenue Next 5Y18.62%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VAPO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year VAPO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

VAPO's earnings are expected to grow with 23.77% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y35.65%

EPS Next 3Y23.77%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for VAPO!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VAPOTHERM INC

NYSE:VAPO (12/14/2023, 7:19:45 PM)

1.27

+0.08 (+6.72%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap7.80M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-86.17%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	36.12%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.84

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	3.04
Quick Ratio	1.61
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)34.56%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y81.61%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-3.95%

Revenue growth 3Y11.57%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

VAPOTHERM INC (VAPO)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens